PBRM1-BD2-IN-4
PBRM1-BD2-IN-4 is a PBRM1-BD2 inhibitor with an IC50 of 0.2 μM, and its Kd values for PBRM1-BD2 and PBRM1-BD5 are 5.5 μM and 11.1 μM, respectively. PBRM1-BD2-IN-4 selectively inhibits the proliferation of PBRM1-dependent prostate cancer cells. PBRM1-BD2-IN-4 can be used in studies related to prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 2819989-60-9
- Formula: C15H13ClN2O
- Molecular Weight:272.73
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All SWI/SNF Complex Isoforms
More
Biological Activity
|
BD2 0.2 μM (IC50) |
PBRM1-BD2-IN-4 (Compound 12) (0.1-10 μM; 5 days) inhibits the proliferation of LNCaP cells in a dose-dependent manner, while exerts no significant effect on PC3 and PWPE-1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LNCaP, PC3 and PWPE-1 cell
-
Concentration:0.1, 1 and 10 μM
-
Incubation Time:5 days
-
Result:Inhibited the proliferation of LNCaP cells in a dose-dependent manner, while exerts no significant effect on PC3 and PWPE-1 cells.
Chemical Information
-
CAS No. 2819989-60-9
-
Molecular Weight 272.73
-
Formula C15H13ClN2O
-
SMILES
O=C1NC(C2=CC=CC=C2C)NC3=C1C(Cl)=CC=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)